Efficacy and safety of glycoprotein IIb/IIIa inhibitors during elective coronary revascularization: A meta-analysis of randomized trials performed in the era of stents and thienopyridines

Journal of the American College of Cardiology

Volumn 57, Issue 10, 2011, Pages 1190-1199

  Winchester, David E ^a   Wen, Xuerong ^b   Brearley, William D ^a   Park, Ki E ^a   Anderson, R David ^a   Bavry, Anthony A ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

bleeding; glycoprotein IIb IIIa inhibitors; meta analysis; percutaneous coronary intervention; post procedural myocardial infarction

Indexed keywords

ABCIXIMAB; CLOPIDOGREL; CREATINE KINASE MB; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRULOG; PLACEBO; THIENOPYRIDINE DERIVATIVE; TICLOPIDINE; TIROFIBAN; TROPONIN;

ADULT; AGED; ARTICLE; BLEEDING; BLOOD CLOT LYSIS; CONTROLLED STUDY; CORONARY STENT; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; FEMALE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RISK ASSESSMENT; STROKE; THROMBOCYTOPENIA;

ANGIOPLASTY, BALLOON, CORONARY; ANTIBODIES, MONOCLONAL; CORONARY DISEASE; HEMORRHAGE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MODELS, STATISTICAL; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STENTS; THIENOPYRIDINES; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 79952293499     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2010.10.030     Document Type: Article

References (56)

1. EPIC Investigators Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. The EPIC Investigation N Engl J Med 330 1994 956 961
2. EPILOG Investigators Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization N Engl J Med 336 1997 1689 1696
3. The CAPTURE Investigators Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study Lancet 349 1997 1429 1435
4. U. Sigwart, J. Puel, V. Mirkovitch, F. Joffre, and L. Kappenberger Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty N Engl J Med 316 1987 701 706 (Pubitemid 17036474)
5. G.S. Roubin, A.D. Cannon, and S.K. Agrawal Intracoronary stenting for acute and threatened closure complicating percutaneous transluminal coronary angioplasty Circulation 85 1992 916 927
6. P.W. Serruys, P. de Jaegere, and F. Kiemeneij A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease Benestent Study Group N Engl J Med 331 1994 489 495 (Pubitemid 24256751)
7. D.L. Fischman, M.B. Leon, D.S. Baim Stent Restenosis Study Investigators A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease N Engl J Med 331 1994 496 501 (Pubitemid 24256752)
8. A. Schomig, F.J. Neumann, and A. Kastrati A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents N Engl J Med 334 1996 1084 1089 (Pubitemid 26120185)
9. M.B. Leon, D.S. Baim, J.J. Popma Stent Anticoagulation Restenosis Study Investigators A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting N Engl J Med 339 1998 1665 1671 (Pubitemid 28550691)
10. A. Kastrati, J. Mehilli, and H. Schuhlen A clinical trial of abciximab in elective percutaneous coronary intervention after pretreatment with clopidogrel N Engl J Med 350 2004 232 238 (Pubitemid 38071801)
11. J. Mehilli, A. Kastrati, and H. Schuhlen Randomized clinical trial of abciximab in diabetic patients undergoing elective percutaneous coronary interventions after treatment with a high loading dose of clopidogrel Circulation 110 2004 3627 3635 (Pubitemid 40003783)
12. R. Pannu, and R. Andraws Effects of glycoprotein IIb/IIIa inhibitors in patients undergoing percutaneous coronary intervention after pretreatment with clopidogrel: a meta-analysis of randomized trials Crit Pathw Cardiol 7 2008 5 10
13. S.C. Smith Jr, T.E. Feldman, and J.W. Hirshfeld Jr ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention) J Am Coll Cardiol 47 2006 e1 e121
14. W. Wijns, P. Kolh, and N. Danchin Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Eur Heart J 31 2010 2501 2555
15. P. Juni, D.G. Altman, and M. Egger Systematic reviews in health care: assessing the quality of controlled clinical trials BMJ 323 2001 42 46 (Pubitemid 32682008)
16. C.B. Begg, and M. Mazumdar Operating characteristics of a rank correlation test for publication bias Biometrics 50 1994 1088 1101
17. M. Egger, G. Davey Smith, M. Schneider, and C. Minder Bias in meta-analysis detected by a simple, graphical test BMJ 315 1997 629 634 (Pubitemid 27387172)
18. J.P. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analyses BMJ 327 2003 557 560 (Pubitemid 37088507)
19. A. Liberati, D.G. Altman, and J. Tetzlaff The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration BMJ 339 2009 b2700
20. S.G. Thompson, and J.P. Higgins How should meta-regression analyses be undertaken and interpreted? Stat Med 21 2002 1559 1573 (Pubitemid 34746063)
21. M. Valgimigli, G. Campo, and N. de Cesare Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double-blind, prospective, randomized Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel study Circulation 119 2009 3215 3222
22. G.P. Talarico, M. Brancati, and F. Burzotta Glycoprotein IIB/IIIA inhibitor to reduce postpercutaneous coronary intervention myonecrosis and improve coronary flow in diabetics: the 'OPTIMIZE-IT' pilot randomized study J Cardiovasc Med (Hagerstown) 10 2009 245 251
23. P.A. Gurbel, K.P. Bliden, and J.F. Saucedo Bivalirudin and clopidogrel with and without eptifibatide for elective stenting: effects on platelet function, thrombelastographic indexes, and their relation to periprocedural infarction results of the CLEAR PLATELETS-2 (Clopidogrel with Eptifibatide to Arrest the Reactivity of Platelets) study J Am Coll Cardiol 53 2009 648 657
24. L. De Luca, G. Sardella, G. De Persio, A. Petrolini, and F. Fedele Impact of abciximab on coronary restenosis in diabetic patients undergoing elective paclitaxel-eluting stent implantation A prospective, randomized, placebo-controlled study Acute Card Care 10 2008 93 99 (Pubitemid 351883446)
25. T. Cuisset, C. Frere, and J. Quilici Glycoprotein IIb/IIIa inhibitors improve outcome after coronary stenting in clopidogrel nonresponders: a prospective, randomized study J Am Coll Cardiol Intv 1 2008 649 653
26. W.H. Chen, U. Kaul, and S.K. Leung A randomized, double-blind, placebo-controlled trial of abciximab for prevention of in-stent restenosis in diabetic patients after coronary stenting: results of the ASIAD (Abciximab in Stenting Inhibits restenosis Among Diabetics) Trial J Invasive Cardiol 17 2005 534 538
27. F. Prati, P. Kwiatkowski, and C. Caroselli Use of abciximab prevents microcirculatory impairment in patients treated with coronary angioplasty for unstable angina: results of a prospective randomized study Catheter Cardiovasc Interv 66 2005 165 169 (Pubitemid 41443019)
28. V. Kurowski, R. Toelg, and D. Jain Effect of adjunctive treatment with tirofiban on troponin T elevation during stenting of critically stenosed aortocoronary saphenous vein grafts Am J Cardiol 96 2005 681 684 (Pubitemid 41207313)
29. L. De Luca, G. De Persio, M. Minati, C. Iacoboni, and F. Fedele Effects of abciximab and preprocedural glycemic control in diabetic patients undergoing elective coronary stenting Am Heart J 149 2005 1135
30. P.A. Gurbel, K.P. Bliden, K.A. Zaman, J.A. Yoho, K.M. Hayes, and U.S. Tantry Clopidogrel loading with eptifibatide to arrest the reactivity of platelets: results of the Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets (CLEAR PLATELETS) study Circulation 111 2005 1153 1159 (Pubitemid 40365477)
31. M.J. Claeys, M.G. Van der Planken, and J.M. Bosmans Does pre-treatment with aspirin and loading dose clopidogrel obviate the need for glycoprotein IIb/IIIa antagonists during elective coronary stenting? A focus on peri-procedural myonecrosis Eur Heart J 26 2005 567 575 (Pubitemid 40461098)
32. J. Hausleiter, A. Kastrati, and J. Mehilli A randomized trial comparing phosphorylcholine-coated stenting with balloon angioplasty as well as abciximab with placebo for restenosis reduction in small coronary arteries J Intern Med 256 2004 388 397 (Pubitemid 39434375)
33. E. Okmen, A. Sanli, H. Uyarel, S. Dayi, Z. Tartan, and N. Cam Effects of glycoprotein IIb/IIIa receptor inhibition with tirofiban on minor myocardial damage in angiographically successful percutaneous coronary angioplasty Cardiology 102 2004 18 23 (Pubitemid 38490256)
34. A.J. Chaves, A.G. Sousa, and L.A. Mattos Volumetric analysis of in-stent intimal hyperplasia in diabetic patients treated with or without abciximab: results of the Diabetes Abciximab steNT Evaluation (DANTE) randomized trial Circulation 109 2004 861 866 (Pubitemid 38252738)
35. C.P. Juergens, H.D. White, and J.A. Belardi A multicenter study of the tolerability of tirofiban versus placebo in patients undergoing planned intracoronary stent placement Clin Ther 24 2002 1332 1344 (Pubitemid 35026156)
36. C. Tamburino, G. Russo, and A. Nicosia Prophylactic abciximab in elective coronary stenting: results of a randomized trial J Invasive Cardiol 14 2002 72 79
37. A.W. Bonz, B. Lengenfelder, and J. Strotmann Effect of additional temporary glycoprotein IIb/IIIa receptor inhibition on troponin release in elective percutaneous coronary interventions after pretreatment with aspirin and clopidogrel (TOPSTAR trial) J Am Coll Cardiol 40 2002 662 668 (Pubitemid 34925612)
38. J.C. O'Shea, G.E. Hafley, and S. Greenberg Platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention: the ESPRIT trial: a randomized controlled trial JAMA 285 2001 2468 2473 (Pubitemid 32433840)
39. A.R. Galassi, G. Russo, and A. Nicosia Usefulness of platelet glycoprotein IIb/IIIa inhibitors in coronary stenting for reconstruction of complex lesions: procedural and 30 day outcome Cardiologia 44 1999 639 645
40. EPISTENT Investigators Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade Lancet 352 1998 87 92
41. D.E. Winchester, and A.A. Bavry Limitations of the MEDLINE database in constructing meta-analyses Ann Intern Med 153 2010 347 348
42. E.J. Topol, D.J. Moliterno, and H.C. Herrmann Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization N Engl J Med 344 2001 1888 1894 (Pubitemid 32553357)
43. J.P. Ioannidis, E. Karvouni, and D.G. Katritsis Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention J Am Coll Cardiol 42 2003 1406 1411 (Pubitemid 37267281)
44. E.J. Topol, J.J. Ferguson, H.F. Weisman EPIC Investigator Group Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta3 blockade with percutaneous coronary intervention Evaluation of platelet IIb/IIIa inhibition for prevention of ischemic complication JAMA 278 1997 479 484 (Pubitemid 27344001)
45. J.B. Lindsey, S.P. Marso, and M. Pencina Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (evaluation of drug-eluting stents and ischemic events) registry J Am Coll Cardiol Intv 2 2009 1074 1082
46. S.V. Manoukian, F. Feit, and R. Mehran Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial J Am Coll Cardiol 49 2007 1362 1368 (Pubitemid 46476844)
47. G. De Luca, E. Navarese, and P. Marino Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials Eur Heart J 30 2009 2705 2713
48. S.R. Mehta, S. Yusuf, and R.J. Peters Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study Lancet 358 2001 527 533 (Pubitemid 32772726)
49. S.R. Steinhubl, P.B. Berger, and J.T. Mann 3rd Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial JAMA 288 2002 2411 2420 (Pubitemid 35340537)
50. H. Thiele, K. Schindler, and J. Friedenberger Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial Circulation 118 2008 49 57
51. A.Y. Fung, J. Saw, and A. Starovoytov Abbreviated infusion of eptifibatide after successful coronary intervention The BRIEF-PCI (Brief Infusion of Eptifibatide Following Percutaneous Coronary Intervention) randomized trial J Am Coll Cardiol 53 2009 837 845
52. S.D. Wiviott, E. Braunwald, and C.H. McCabe Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015 (Pubitemid 350106708)
53. L. Wallentin, R.C. Becker, and A. Budaj Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057
54. D.L. Bhatt, A.M. Lincoff, and C.M. Gibson Intravenous platelet blockade with cangrelor during PCI N Engl J Med 361 2009 2330 2341
55. D.E. Winchester, X. Wen, L. Xie, and A.A. Bavry Evidence of pre-procedural statin therapy a meta-analysis of randomized trials J Am Coll Cardiol 56 2010 1099 1109
56. D.L. Bhatt, M.E. Bertrand, and P.B. Berger Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting J Am Coll Cardiol 39 2002 9 14 (Pubitemid 34059855)